Pathogenetic basis of Takenouchi-Kosaki syndrome: Electron microscopy study using platelets in patients and functional studies in a Caenorhabditis elegans model.
Tomoko UeharaHidenori SuzukiNobuhiko OkamotoTatsuro KondohAyesha AhmadBridget C O'ConnorSawako YoshinaShohei MitaniKenjiro KosakiToshiki TakenouchiPublished in: Scientific reports (2019)
The combined phenotype of thrombocytopenia accompanied by intellectual disability in patients with a de novo heterozygous mutation, i.e., p.Tyr64Cys in CDC42, signifies a clinically recognizable novel syndrome that has been eponymized as "Takenouchi-Kosaki syndrome" (OMIM #616737). In the present study, a detailed phenotypic analysis performed for a total of five patients with Takenouchi-Kosaki syndrome revealed that intellectual disability, macrothrombocytopenia, camptodactyly, structural brain abnormalities with sensorineural deafness, hypothyroidism, and frequent infections comprise the cardinal features of this condition. A morphologic analysis of platelets derived from three affected individuals was performed using electron microscopy. The platelets of the three patients were large and spherical in shape. Furthermore, platelet α-granules were decreased, while vacuoles were increased. We further performed a functional analysis of p.Tyr64Cys in CDC42 through CRISPR/Cas9-mediated gene editing in a Caenorhabditis elegans model. This functional analysis suggested that the mutant allele has hypomorphic effects. Takenouchi-Kosaki syndrome is clinically recognizable by the combined phenotype of intellectual disability, macrothrombocytopenia, camptodactyly, structural brain abnormalities with sensorineural deafness, hypothyroidism, and frequent infections as well as the identification of a heterozygous de novo mutation in CDC42, i.e., p.Tyr64Cys.
Keyphrases
- intellectual disability
- autism spectrum disorder
- end stage renal disease
- electron microscopy
- crispr cas
- case report
- chronic kidney disease
- ejection fraction
- newly diagnosed
- prognostic factors
- hearing loss
- early onset
- cell cycle
- peritoneal dialysis
- white matter
- patient reported outcomes
- resting state
- cell proliferation
- functional connectivity